- Home
- CIA vs NVCT Comparison
CIA vs NVCT Comparison
Compare CIA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIA | NVCT |
|---|---|---|
| Founded | 1969 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 251.0M | 220.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CIA | NVCT |
|---|---|---|
| Price | $5.65 | $8.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 78.1K | 70.2K |
| Earning Date | 03-12-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $247,020,000.00 | N/A |
| Revenue This Year | $3.65 | N/A |
| Revenue Next Year | $3.51 | N/A |
| P/E Ratio | $26.28 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $5.55 |
| 52 Week High | $6.36 | $11.52 |
Technical Indicators
Market Signals| Indicator | CIA | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 56.71 |
| Support Level | $5.12 | $8.08 |
| Resistance Level | $5.65 | $8.93 |
| Average True Range (ATR) | 0.33 | 0.49 |
| MACD | 0.08 | -0.05 |
| Stochastic Oscillator | 99.09 | 36.45 |
Price Performance
Historical ComparisonAbout CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.